Abstract
Purpose of Review
The purpose of this review is to discuss migraine and RLS diseases and explain the comorbidity of migraine and RLS and possible mechanisms leading to this comorbidity in the light of recent studies.
Recent Findings
Many clinical and epidemiological studies and recent meta-analyses of these studies have revealed a higher prevalence of RLS in patients with migraine compared to individuals without migraine.
Summary
There is an association between RLS and migraine in terms of some action mechanisms, especially the dopaminergic system, and some symptoms. They are associated concerning burden and economic cost. It will be extremely useful to take this situation into account in order to choose the appropriate drug for both, reduce the side effects of the drugs, increase patient satisfaction, and decrease the cost of treatment.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Suzuki K, Suzuki S, Haruyama Y, Kobashi G, Shiina T, Hirata K. Restless legs syndrome is associated with headache-related disabilities in patients with migraine: a prospective 7-year follow-up study. Eur J Neurol. 2019;26(2):238–45. https://doi.org/10.1111/ene.13796. The authors reported that RLS had a significant impact on headache-related disability in patients with migraine. This is the first prospective study on this subject.
•• Yang X, Liu B, Yang B, Li S, Wang F, Li K, et al. Prevalence of restless legs syndrome in individuals with migraine: a systematic review and meta-analysis of observational studies. Neurol Sci. 2018;39(11):1927–34. https://doi.org/10.1007/s10072-018-3527-7. This study comprehensively evaluated the available evidence to estimate the prevalence of RLS in subjects with migraine and non-migraine controls. Their meta-analysis provides the first reliable pooled estimate of RLS prevalence among individuals with migraine, and it provides strong evidence that RLS risk is higher among individuals with migraine than among controls.
Yang FC, Lin TY, Chen HJ, Lee JT, Lin CC, Huang WY, et al. Increased risk of restless legs syndrome in patients with migraine: a nationwide population-based cohort study. Medicine (Baltimore). 2016;95(5):e2646. https://doi.org/10.1097/MD.0000000000002646.
Schürks M, Winter A, Berger K, Kurth T. Migraine and restless legs syndrome: a systematic review. Cephalalgia. 2014;34(10):777–94. https://doi.org/10.1177/0333102414537725.
Akdag Uzun Z, Kurt S, Karaer UH. The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients. Neurol Sci. 2018;39(8):1409–14. https://doi.org/10.1007/s10072-018-3438-7.
Angriman M, Cortese S, Bruni O. Somatic and neuropsychiatric comorbidities in pediatric restless legs syndrome: a systematic review of the literature. Sleep Med Rev. 2017;34:34–45. https://doi.org/10.1016/j.smrv.2016.06.008.
Sevindik MS, Demirci S, Göksan B, Özge A, Savrun FK, Onur H, et al. Accompanying migrainous features in pediatric migraine patients with restless legs syndrome. Neurol Sci. 2017;38(9):1677–81. https://doi.org/10.1007/s10072-017-3045-z.
Cho SJ, Chung YK, Kim JM, Chu MK. Migraine and restless legs syndrome are associated in adults under age fifty but not in adults over fifty: a population-based study. J Headache Pain. 2015;16:554. https://doi.org/10.1186/s10194-015-0554-0.
Chen PK, Fuh JL, Wang SJ. Bidirectional triggering association between migraine and restless legs syndrome: a diary study. Cephalalgia. 2016;36(5):431–6. https://doi.org/10.1177/0333102415596444.
Chen PK, Wang SJ. Non-headache symptoms in migraine patients. F1000Res. 2018;7:188. https://doi.org/10.12688/f1000research.12447.1 eCollection 2018.
Lin GY, Lin YK, Lee JT, Lee MS, Lin CC, Tsai CK, et al. Prevalence of restless legs syndrome in migraine patients with and without aura: a cross-sectional, case-controlled study. J Headache Pain. 2016;17(1):97. https://doi.org/10.1186/s10194-016-0691-0.
American Headache Society. The American headache society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18. https://doi.org/10.1111/head.13456.
• Charles A. Migraine. N Engl J Med. 2017;377(17):1698–9. https://doi.org/10.1056/NEJMc1711803. The author summarized the diagnosis and treatment of migraine in a very nice and understandable way.
GBD, Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2015;2017(16):877–97. https://doi.org/10.1016/S1474-4422(17)30299-5.
Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–82. https://doi.org/10.1016/S1474-4422(17)30435-0.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. https://doi.org/10.1177/0333102413485658.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.
Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3–20. https://doi.org/10.1111/head.12499.
Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89. https://doi.org/10.1212/CON.0000000000000199.
Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WBF, Adams AM, et al. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain. 2017;18:101. https://doi.org/10.1186/s10194-017-0787-1.
Wijemanne S, Ondo W. Restless legs syndrome: clinical features, diagnosis and a practical approach to management. Pract Neurol. 2017;17:444–52. https://doi.org/10.1136/practneurol-2017-001762.
Kwatra V, Khan M, Quadri SA, Cook TS. Differential diagnosis and treatment of restless legs syndrome: a literature review. 2018;10(9):e3297. https://doi.org/10.7759/cureus.3297.
•• Trenkwalder C, Allen R, Högl B, Clemens S, Patton S, Schormair B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018;17(11):994–1005. https://doi.org/10.1016/S1474-4422(18)30311-9. The authors examined new insights from genetics, and iron and hypoxic pathways to elucidate the strong biological component of RLS.
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. International restless legs syndrome study group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG)consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15(8):860–73. https://doi.org/10.1016/j.sleep.2014.03.025.
American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual (ICSD-3). 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
Becker PM, Novak M. Diagnosis, comorbidities, and management of restless legs syndrome. Curr Med Res Opin. 2014;30(8):1441–60. https://doi.org/10.1185/03007995.2014.918029.
Aydar G, Kurt S, Karaer Unaldi H, Erkorkmaz U. Restless legs syndrome in multiple sclerosis. Eur Neurol. 2011;65(5):302–6. https://doi.org/10.1159/000327315.
•• Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, et al. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)(§). Mov Disord. 2018;33(7):1077–91. https://doi.org/10.1002/mds.27260. The authors updated the previous evidence-based medicine review of treatments for RLS. All randomized, controlled trials (level I) with a high quality score published between January 2007 and January 2017 were reviewed.
Dosi C, Figura M, Ferri R, Bruni O. Sleep and headache. Semin Pediatr Neurol. 2015;22(2):105–12. https://doi.org/10.1016/j.spen.2015.04.005.
Nesbitt AD, Leschziner GD, Peatfield RC. Headache, drugs and sleep. Cephalalgia. 2014;34(10):756–66. https://doi.org/10.1177/0333102414542662.
Mitelman SA. Transdiagnostic neuroimaging in psychiatry: a review. Psychiatry Res. 2019;277:23–38. https://doi.org/10.1016/j.psychres.2019.01.026.
Sawaddiruk P, Paiboonworachat S, Chattipakorn N, Chattipakorn SC. Alterations of brain activity in fibromyalgia patients. J Clin Neurosci. 2017;38:13–22. https://doi.org/10.1016/j.jocn.2016.12.014.
Ferini-Strambi L, Galbiati A, Combi R. Sleep disorder-related headaches. Neurol Sci. 2019;40(Suppl 1):107–13. https://doi.org/10.1007/s10072-019-03837-z.
van Oosterhout WP, van Someren EJ, Louter MA, Schoonman GG, Lammers GJ, Rijsman RM, et al. Restless legs syndrome in migraine patients: prevalence and severity. Eur J Neurol. 2016;23(6):1110–6. https://doi.org/10.1111/ene.12993.
Gozubatik-Celik G, Benbir G, Tan F, Karadeniz D, Goksan B. The prevalence of migraine in restless legs syndrome. Headache. 2014;54(5):872–7. https://doi.org/10.1111/head.12288.
Zanigni S, Giannini G, Melotti R, Pattaro C, Provini F, Cevoli S, et al. Association between restless legs syndrome and migraine: a population-based study. Eur J Neurol. 2014;21(9):1205–10. https://doi.org/10.1111/ene.12462.
Sezer S, Kurt S, Ates O. Analysis of dopamine beta hydroxylase gene polymorphisms in migraine. Clin Neurol Neurosurg. 2016;145:96–100. https://doi.org/10.1016/j.clineuro.2016.02.002.
Acar BA, Acar T, Alagöz AN, Karacan A, Varım C, Uyanık MŞ, et al. Relationship between primary restless legs syndrome and migraine with aura. Kaohsiung J Med Sci. 2016;32(8):420–6. https://doi.org/10.1016/j.kjms.2016.06.003.
Valente M, Janes F, Russo V, Fontana A, Travanut A, Sommaro M, et al. Prevalence of restless legs syndrome in migraine patients: a case-control study. Analysis of risk factors for restless legs syndrome in migraine patients. Headache. 2017;57(7):1088–95. https://doi.org/10.1111/head.13124.
Fuh JL, Chung MY, Yao SC, Chen PK, Liao YC, Hsu CL, et al. Susceptible genes of restless legs syndrome in migraine. Cephalalgia. 2016;36(11):1028–37. https://doi.org/10.1177/0333102415620907.
Szentkirályi A, Völzke H, Hoffmann W, Winkelmann J, Berger K. Lack of association between genetic risk loci for restless legs syndrome and multimorbidity. Sleep. 2016;39(1):111–5. https://doi.org/10.5665/sleep.5328.
Yang FC, Chou KH, Hsu AL, Fuh JL, Lirng JF, Kao HW, et al. Altered brain functional connectome in migraine with and without restless legs syndrome: a resting-state functional MRI study. Front Neurol. 2018;9:25. https://doi.org/10.3389/fneur.2018.00025.
Raggi A. Can we now say that commonalities between restless leg syndrome and migraine exist? Neurol Sci. 2019;40(1):227–8. https://doi.org/10.1007/s10072-018-3591-z.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not include any study conducted by the author with human or animal subjects.
Conflict of Interest
The author declares no conflict of interests concerning the publication of this article.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Sleep
Rights and permissions
About this article
Cite this article
Kurt, S. The Comorbidity of Migraine and Restless Legs Syndrome. Curr Neurol Neurosci Rep 19, 60 (2019). https://doi.org/10.1007/s11910-019-0977-0
Published:
DOI: https://doi.org/10.1007/s11910-019-0977-0